Inventor · disambiguated record
James Ernst
Also filed as: ERNST JAMES · ERNST JAMES A · ERNST JAMES ANDREW
16 granted patents·11 pending applications·159 citations·filing 2005–2025
92Inventor score
Top patents by PatentIndex Score
27 records- 0197US9708406B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jul 18, 2017·87 cites·51 claims
- 0294US7947277B2Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disordersGENENTECH INC·Filed 2007·Granted May 24, 2011·33 cites·13 claims
- 0392US10808036B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2017·Granted Oct 20, 2020·5 cites·48 claims
- 0490US7691989B2Methods for producing soluble membrane-spanning proteinsGENENTECH INC·Filed 2005·Granted Apr 6, 2010·10 cites·35 claims
- 0588US10508151B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2015·Granted Dec 17, 2019·7 cites·40 claims
- 0686US7829684B2Methods for producing soluble membrane-spanning proteinsGENENTECH INC·Filed 2009·Granted Nov 9, 2010·5 cites·58 claims
- 0786US2025011471A1Antibodies and methods of useGENENTCH INC·Filed 2024·Application pending·0 cites
- 0884US2024026033A1Antibodies and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 0983US11008403B2Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of useGENENTECH INC·Filed 2015·Granted May 18, 2021·3 cites·25 claims
- 1080US7820806B2Methods for producing soluble membrane spanning proteinsGENENTECH INC·Filed 2009·Granted Oct 26, 2010·2 cites·33 claims
- 1175US9884919B2Methods of treatment with bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1GENENTECH INC·Filed 2016·Granted Feb 6, 2018·1 cites·16 claims
- 1275US2022064331A1Antibodies and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 1374US8846041B2Anti-LRP6 antibodiesBOURHIS ERIC·Filed 2011·Granted Sep 30, 2014·6 cites·16 claims
- 1470US10882921B2Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody productionGENENTECH INC·Filed 2019·Granted Jan 5, 2021·0 cites·21 claims
- 1567US9873748B2Bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1GENENTECH INC·Filed 2014·Granted Jan 23, 2018·0 cites·12 claims
- 1666US11098129B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2019·Granted Aug 24, 2021·0 cites·34 claims
- 1765US2021087288A1Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2020·Application pending·0 cites
- 1864US10246518B2Nucleic acids encoding bispecific antibodies binding to beta-Klotho and fibroblast growth factor receptor 1GENENTECH INC·Filed 2017·Granted Apr 2, 2019·0 cites·5 claims
- 1957US2017349639A1Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disordersGENENTECH INC·Filed 2016·Application pending·0 cites
- 2054US9556267B2Anti-LRP6 antibodiesGENENTECH INC·Filed 2014·Granted Jan 31, 2017·0 cites·10 claims
- 2153US2025361311A1Anti-tnf-like ligand 1a (tl1a) antibodiesXENCOR INC·Filed 2025·Application pending·0 cites
- 2252US2010266593A1Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disordersGENENTECH INC·Filed 2010·Application pending·0 cites
- 2351US8323902B2Methods for producing soluble membrane-spanning proteinsERNST JAMES A·Filed 2010·Granted Dec 4, 2012·0 cites·31 claims
- 2450US2012141481A1Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disordersERNST JAMES A·Filed 2012·Application pending·0 cites
- 2550US2022033520A1Modified antibody fcs and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 2648US2011311534A1Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disordersERNST JAMES A·Filed 2011·Application pending·0 cites
- 2747US2020055896A1Substrates recognized by fibroblast activation protein (fap) and methods of using the sameGENENTECH INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Ernst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →